Publikation

Efficacy of natalizumab in second line therapy of relapsing-remitting multiple sclerosis: results from a multi-center study in German speaking countries

Wissenschaftlicher Artikel/Review - 07.06.2010

Tettenborn Barbara, Putzki Norman, Yaldizli Oezguer, Mäurer M, Cursiefen S, Kuckert S, Maschke M, Limmroth V